linkedin

Key Executives

  • John Rim
    John Rim
    President & CEO
    John Rim is President & CEO at Samsung Biologics.
    Prior to joining Samsung Biologics in 2018, Mr. Rim worked for Genentech/Roche in a variety of senior global leadership roles in Technical Operations, Product Development, and Research and Development in the US and Europe.

    Mr. Rim has also held senior leadership roles with Astellas Pharmaceuticals in General Management, Sales & Marketing, Technical Operations, Customer Service, Business Development, and Strategic Planning.

    Mr. Rim has over 30 years’ experience in the biopharmaceutical industry and began his career as a management consultant with Booz, Allen & Hamilton consulting to pharmaceutical companies in the US and Europe.

    Mr. Rim holds a bachelor’s degree from Columbia University, a master’s degree from Stanford University, and an MBA from the Kellogg School of Management at Northwestern University.
  • James Park
    James Park
    Executive Vice President & CBO
    James Park is Executive Vice President and Managing Director of the Global Sales Center.
    Prior to joining Samsung Biologics in 2015, Mr. Park held various technical and operational positions, as well as business development management leadership positions in biopharmaceutical companies in the U.S.

    Mr. Park began his career in 1989 with ALZA Corporation, a subsidiary of J & J, as a chemical engineer where he participated and led process and product development, technology transfer, validation and commercialization of several OROS products. Mr. Park then worked in Technical & Alliance Management at Watson Pharmaceuticals. Transitioning to Merck as a Change Agent/Six Sigma Project Manager, Mr. Park then managed the Operational Excellence projects related to process improvements, cost savings and quality initiatives.

    From 2004 to 2015, Mr. Park participated in and directed 100+ CMC due diligences on assets ranging from pre-clinical to commercial products, and managed Global Manufacturing & Supply BD activities including Licensing, Outsourcing and M&A at Bristol-Myers Squibb.

    Mr. Park has over 25 years of experience in the biopharmaceutical and pharmaceutical industries.
  • Pierre Catignol
    Pierre Catignol
    Executive Vice President
    Pierre Catignol is Executive Vice President and Head of Manufacturing center at Samsung Biologics.
    Mr. Catignol has over 25 years of experience in the biopharmaceutical and pharmaceutical industry.

    Prior to joining Samsung Biologics, Mr. Catignol began his career at Sanofi-Pasteur in 1995, and extended his career in StALLERGENES AND VIRBAC as Head of Operations & Supply site and Operations & Quality respectively.

    His recent leadership role was at Lonza as Head of Portsmouth site.

    Mr. Catignol holds a master's degree for General Engineering at ECAM university.
  • Kun Lo, Ph.D.
    Kun Lo, Ph.D.
    Executive Vice President
    Dr. Kun Lo is Executive Vice President and Head of EPCV center responsible for construction and operation of new plants.
    Prior to joining Samsung Biologics in 2020, Dr. Lo held various management positions in Engineering and New Business.

    Dr. Lo began his career with Samsung General Chemicals in 1992, then developed chemical products and managed manufacturing for 18 years in Samsung Total Petrochemical. In 2013, Dr. Lo advanced through Engineering expertise as a manager of Engineering Support Team and Process Design in Samsung Engineering.

    Dr. Lo assumed responsibilities for planning global business as a New Business Team Leader and Head of US corporation in Samsung Engineering.

    Dr. Lo holds a doctor’s degree from Seoul National University in Chemical Engineering.
  • Sam Machour
    Sam Machour
    Executive Vice President & CQO
    Sam Machour is Executive Vice President and Chief Quality Officer in charge of Quality, Regulatory and Compliance at Samsung Biologics.
    Prior to joining Samsung Biologics in 2019, Mr. Machour spent more than 32 years supporting MedTech, bioscience and biopharmaceutical companies achieve business operational excellence and gain leadership in the areas of Research & Development, Quality, Regulatory, Operations and product commercialization.

    Mr. Machour served at several big pharma including Pfizer, GSK and J&J and held global leadership roles at Lonza as its Vice-President and Global Head for Quality and Regulatory and member of the Biologics Executive Committee and at Becton Dickinson as the Global Vice-President of Quality Operations, in charge of Quality, Regulatory and Compliance.

    Mr. Machour is Director of Executives Without Borders, is a member of the Africa CDC Partnerships for African Vaccine Manufacturing (PAVM) and is the Vice-Chair, in Korea, of the George Mason University Advisory Committee, helping improve the delivery of education.
  • Andy Yongsin Kim
    Andy Yongsin Kim
    Executive Vice President
    Andy Yongsin Kim is Executive Vice President and Head of Business Operation center at Samsung Biologics.
    Prior to joining Samsung Biologics in 2010, Mr. Kim was at Samsung Electronics, where he began his career in 1987, as Director of Human Resources for the Visual Display Division.

    Most notably, Mr. Kim carried out his duties from 2004 to 2009 by establishing Samsung’s new brand presence in three countries in Eastern Europe (HU,CZ,SK), supporting sales & manufacturing, and overseeing all HR affairs.
  • Sangyoon Lee, Ph.D.
    Sangyoon Lee, Ph.D.
    Vice President
    Dr. Sangyoon Lee is Vice President and Head of Technology Support center at Samsung Biologics.
    Prior to joining Samsung Biologics in 2021, Dr. Lee held various management positions in Technical Operations and Manufacturing.

    Dr. Lee began his career in the pharmaceutical industry in 2004, overseeing Technical & Supply Operations and Drug Product Manufacturing where he was promoted to Senior Vice President to lead the Global Operations Division in 2019.

    Dr. Lee holds a Ph.D. in Bioengineering.
  • Dongjoong Kim
    Dongjoong Kim
    Executive Vice President & CFO
    Dongjoong Kim is Executive Vice President and Managing Director in charge of the Business Support Center which includes the Finance Team, Business Strategy Team and Business Planning Team.
    Prior to joining Samsung Biologics in 2014, Mr. Kim held various corporate planning and managerial leadership positions for Samsung Electronics.

    Mr. Kim began his career with Samsung in 1988. Mr. Kim led the Corporate Management and Administration of Samsung Electronics from 2002 to 2014.
  • James Choi
    James Choi
    Executive Vice President & CIMO
    James Choi is Executive Vice President and Chief Information & Marketing Officer and head of Global Public Relations and Process Improvement at Samsung Biologics.
    Prior to joining Samsung Biologics in 2014, Mr. Choi held various technology and operations leadership positions at major global healthcare and informatics corporations.

    Mr. Choi began his career with Philips Healthcare in 1989 as Site Planning Manager and advanced through leadership positions in Customer Service eBusiness and Technology, Operations, and Information Systems for North America.

    Mr. Choi then transitioned to the Informatics and Security industry and was CIO for a major background investigations, insurance intelligence, and commercial pre-employment screening company. Mr. Choi most recently served as CIO for Beckman Coulter’s Clinical Diagnostics and Life Sciences companies.

    Mr. Choi has over 30 years of leadership experience and holds a bachelors degree in Mechanical Engineering from the University of California Irvine and an MBA from the University of Southern California.
  • Yong Park
    Yong Park
    Vice President & CHRO
    Yong Park is Vice President and Head of HR Support Center at Samsung Biologics.
    Mr. Park has over 25 years of experience in managing human resources.

    Prior to joining Samsung Biologics, Mr. Park began his career at Samsung Electronics as HR manager for the headquarters, and expanded his experience at Samsung Electronics by overseeing HR team for Western Asia and North America.

    Mr. Park holds an MBA from Purdue University.
  • Jahoon Kang
    Jahoon Kang
    Vice President
    Jahoon Kang is Vice President and Head of CDO at Samsung Biologics.
    Ms. Kang has over 25 years of experience in clinical research and development in the biopharmaceutical and pharmaceutical industries.

    Ms. Kang began her career at Chong Kun Dang in 1999 as a Clinical Research Associate, then transitioned to Novartis, overseeing clinical operations in Korea and also clinical projects in Siwtzerland headsquarters.

    Ms. Kang expanded her career at Hanmi Science in 2015 as Vice President for Clinical Research and Development division, and co-founded Lumebio in 2019.
  • Sangwon Seo
    Sangwon Seo
    Vice President
    Sangwon Seo is Vice President and Head of Business Strategy at Samsung Biologics.
    Prior to joining Samsung Biologics in 2011, Mr. Seo was at Samsung Electronics.

    Mr. Seo acquired a M.S. in Bioengineering from POSTECH.
  • Doyoung Heo
    Doyoung Heo
    Vice President
    Doyoung Heo is Vice President and Head of Finance and Investor Relations at Samsung Biologics.
    Mr. Heo transitioned to Samsung Biologics from Samsung Electronics.

    Mr. Heo holds a bachelor degree in business management at Korea University and acquired an MBA from the University of Indiana.
  • Heekyun Lim
    Heekyun Lim
    Vice President
    Heekyun Lim is Vice President and Head of Business Consulting Team at Samsung Biologics.
    Mr. Lim has over 20 years of experience with extensive expertise in strategic management and bio research for Samsung Electronics.

    Mr. Lim holds a master’s degree for life sciences from Pohang University of Science and Technology.
  • Hyungwoo Moon
    Hyungwoo Moon
    Vice President
    Hyungwoo Moon is Vice President and Head of Legal Compliance Team at Samsung Biologics.
    Mr. Moon began his career at Yang Hyun law firm in Korea in 2006, specializing in M&A and Fair Trade Act.

    Mr. Moon holds a law degree and master’s degree for law from Seoul National University.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved